Henry Schein Sets New 52-Week High at $121.00 (HSIC)
Henry Schein (NASDAQ:HSIC)’s share price reached a new 52-week high during trading on Thursday , AnalystRatings.NET reports. The company traded as high as $121.00 and last traded at $118.91, with a volume of 147,445 shares. The stock had previously closed at $119.54.
Several analysts have recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Henry Schein in a research note on Friday, August 29th. They now have a $125.00 price target on the stock. Separately, analysts at Credit Suisse reiterated a “neutral” rating on shares of Henry Schein in a research note on Tuesday, August 5th. They now have a $121.00 price target on the stock, up previously from $120.00. Finally, analysts at Leerink Swann raised their price target on shares of Henry Schein from $120.00 to $127.00 in a research note on Tuesday, August 5th. They now have a “market perform” rating on the stock. Four analysts have rated the stock with a hold rating and one has given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $123.60.
The stock’s 50-day moving average is $118.2 and its 200-day moving average is $117.6. The company has a market cap of $10.071 billion and a P/E ratio of 23.02.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Monday, August 4th. The company reported $1.35 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.33 by $0.02. The company had revenue of $2.60 billion for the quarter, compared to the consensus estimate of $2.56 billion. During the same quarter in the prior year, the company posted $1.23 earnings per share. The company’s quarterly revenue was up 9.3% on a year-over-year basis. Analysts expect that Henry Schein will post $5.38 EPS for the current fiscal year.
In other Henry Schein news, Director Philip A. Laskawy sold 15,438 shares of the stock on the open market in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $119.40, for a total value of $1,843,297.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Henry Schein, Inc is a provider of health care products and services to office-based practitioners. The Company conducts its business through two segments: healthcare distribution and technology.